Osimertinib

Osimertinib, osimertinib, 1421373-65-0, AZD-9291, AZD9291, Mereletinib, AZD 9291, osimertinibum, N-(2-{[2-(Dimethylamino)ethyl](Methyl)amino}-4-Methoxy-5-{[4-(1-Methyl-1h-Indol-3-Yl)pyrimidin-2-Yl]amino}phenyl)prop-2-Enamide, 3C06JJ0Z2O, AZD-9291 FREE BASE, N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide, N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide, CHEBI:90943, DTXSID501025961, 2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-, N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)prop-2-enamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide, N-(2-(2-(dimethylamino)ethyl-methylamino)-4-methoxy-5-((4-(1-methylindol-3-yl)pyrimidin-2-yl)amino)phenyl)prop-2-enamide, RefChem:58257, L01XE35, DTXCID401510212, Osimertinib [USAN], N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide, UNII-3C06JJ0Z2O, MFCD27988062, C28H33N7O2, Osimertinib (AZD9291), AZD 9291(Osimertinib), Mereletinib [INN], 2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-, N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide, AZD 9291, Osimertinib, Tagrisso, N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)acrylamide, Osimertinib (Standard), OSIMERTINIB [MI], OSIMERTINIB [INN], Osimertinib, AZD 9291, Osimertinib, AZD-9291, mereletinib (obsolete INN), AZD 9291 (Osimertinib), AZD-9291(Osimertinib)?, OSIMERTINIB [WHO-DD], GTPL7719, orb1305406, orb3141352, CHEMBL3353410, SCHEMBL14660911, SCHEMBL29350904, SCHEMBL29378405, EX-A314, MereletinibAZD-9291,Osimertinib, DUYJMQONPNNFPI-UHFFFAOYSA-N, GLXC-05459, HMS3653E10, HMS3672M05, HMS5085F14, MSK11040, NQC28144, TVB02091, BDBM50029668, EBC-07876, HY-15772R, NSC779217, NSC781254, NSC800812, s7297, AKOS025290756, CCG-264683, CS-2018, DB09330, FD58317, NSC-779217, NSC-781254, NSC-800812, SB22952, NCGC00378622-03, NCGC00378622-04, NCGC00378622-10, AC-29019, AS-16943, BP-43647, HY-15772, 4714B, NS00073136, SW219863-1, EN300-7382438, BRD-K42805893-001-04-9, Q21506464, 2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-, AZD 9291, Osimertinib, Tagrisso, N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide, N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)acrylamide, N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide, N-(2-{2-Dimethylaminoethyl-methylamino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide, N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4- (1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide, N-[2-[2-(dimethylamino)ethyl-methyl-amino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide